United States · FDA National Drug Code directory
Fluorouracil
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 63323-117_0c579d19-82e7-4aac-bcb6-b3a60a3b48a3
- Product NDC
- 63323-117
- Form
- INJECTION, SOLUTION
- Composition / generic term
- FLUOROURACIL
- Labeler
- Fresenius Kabi USA, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20170102
- Source listing expiry
- 20271231
Source-listed ingredients
- FLUOROURACIL — 50 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 10 VIAL, SINGLE-DOSE in 1 TRAY (63323-117-10) / 10 mL in 1 VIAL, SINGLE-DOSE (63323-117-00) · 63323-117-10
- 10 VIAL, SINGLE-DOSE in 1 TRAY (63323-117-20) / 20 mL in 1 VIAL, SINGLE-DOSE (63323-117-01) · 63323-117-20
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →